Abstract:Objectives: The aim of this study was to examine a possible relationship between lead nephropathy and its effects on the skeleton in male population occupationally exposed to lead in China. Methods: One hundred and fifty-five lead-exposed male workers in a storage battery plant in Shanghai were selected as the exposed subjects while the 36 healthy male officers in the plant who were not occupationally exposed to lead were treated as the control. Blood lead (BPb) and urine lead were used as biomarkers for exposure. Z score, urine hydroxyproline (HYP), serum alkaline phosphatase (bone isoenzyme) (BALP) and serum osteocalcin (BGP) were used as biomarkers for bone effects. Urine N-acetyl-beta-D-glucosaminidase (UNAG) and urine albumin (UALB) were applied as biomarkers of renal tubular and glomerular dysfunction. Bone mineral density was measured by the monophoton absorptiometry (SPA-4). Results: It was found that there were linear correlate relationships between lead exposure and NAG, ALB, BALP, BGP, HYP, Z score ( P < 0.01), after controlling confounders such as age and work year. NAG, ALB, BALP, BGP and HYP would increase with the increase of lead exposure. Z score would decrease with the increase of lead exposure. Of 21 subjects with osteoporosis, nine subjects were suffering from renal dysfunction. The prevalence of renal dysfunction (42.86%) was significantly higher in the subjects with osteoporosis than in those without osteoporosis (17.65%) (chi(2) = 7.310, P = 0.007). The prevalence of osteoporosis had relationship with renal tubular damage, but not with renal glomerular damage. This showed that glomerular dysfunction plays a smaller role than tubular dysfunction in the causation of bone damage. Benchmark dose in terms of BPb was calculated using Benchmark Dose Software Version 1.3.2 software. The benchmark dose lower limit of a one-sided 95% confidence interval (BMDL) for 10% excess risk was also determined. It was found that BMDL(-05) for BALP, UNAG, BGP, HYP, Z score and UALB of BPb increased sequentially. The BMDL values for UNAG (10.13 mu g dL(-1)) were lower than those of Z score (14.17 mu g dL(-1)). Conclusions: The present study has thus demonstrated the combined adverse effects (osteoporosis and renal dysfunction) caused by occupational exposure to lead. There was a dose-response relationship between lead exposure and prevalence of osteoporosis, renal dysfunction and bone metabolism. The renal dysfunction might develop earlier than osteoporosis. Osteoporosis caused by lead was related to the change of bone metabolism and renal dysfunction, which was especially to tubular damage but not to glomerular damage.

[Application of Benchmark Dose (BMD) in a Bone-Effect Study on a General Population Environmentally Exposed to Cadmium].

Application of the Benchmark Dose (BMD) Method to Identify Thresholds of Cadmium-Induced Renal Effects in Non-Polluted Areas in China.

Benchmark dose for estimation of cadmium reference level for osteoporosis in a Chinese female population

Application of Benchmark Dose (BMD) in Estimating Biological Exposure Limit (BEL) to Cadmium.

Application of Benchmark Dose for Occupational Epidemiology in Lead Exposure

[Application of Benchmark Dose on Occupational Epidemiology Research in Lead Exposure].

Benchmark Dose Estimation for Cadmium-Induced Renal Tubular Damage among Environmental Cadmium-Exposed Women Aged 35-54 Years in Two Counties of China

Benchmark Dose Estimation for Cadmium-Induced Renal Effects Based on a Large Sample Population from Five Chinese Provinces

Estimation of benchmark dose for bone damage and renal dysfunction in a Chinese male population occupationally exposed to lead.

Environmental epidemiological study and estimation of benchmark dose for renal dysfunction in a cadmium-polluted area in China

Benchmark dose estimation of cadmium reference level for hypertension in a Chinese population.

Correlations Between Bone Metabolism Biomarkers and Fluoride Exposure in Adults and Children

Application Of Bmd Approach To Identify Thresholds Of Cadmium-Induced Renal Effect Among 35 To 55 Year-Old Women In Two Cadmium Polluted Counties In China

Benchmark dose estimation of urinary and blood cadmium as biomarkers of renal dysfunction among 40‐75‐year‐old non‐smoking women in rural areas of southwest China

[Application of Benchmark Dose on Renal Injury in People Chronically Exposed to Lead].

A Bayesian Benchmark Concentration Analysis for Urinary Fluoride and Intelligence in Adults in Guizhou, China

Benchmark Dose Approach for Renal Dysfunction in Workers Exposed to Lead

Risk assessment on renal dysfunction caused by co-exposure to arsenic and cadmium using benchmark dose calculation in a Chinese population

[Calculation of the combined renal dysfunction risk in patients co-exposed to arsenicum and cadmium by using benchmark dose method]

Estimation of the benchmark dose of urinary cadmium as the reference level for renal dysfunction: a large sample study in five cadmium polluted areas in China

Benchmark dose modeling for epidemiological dose-response assessment using prospective cohort studies